← All stocks

Baxter International

BAX Net selling
CIK 0000010456 #65 in the set updated 17 Sep 2026
Bought (120 mo)
$803.82K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.93B
$0.00 on a plan · $85.20M straight out of an exercise
Sold at will
$1.85B
18 of 102 sales
Net
−$1.93B
−$1.85B against sales at will

By person

52 insiders · 104 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Third Point LLC entity
Director
$1.85B (5)
−$1.85B
23,008,125
$934.36M
−55.7%
Mason Jeanne K
EVP, Chief HR Officer
$21.39M (9) scheduled
−$21.39M
199,853
$8.12M
+104.2%
Eyre Brik V
SVP, President, Americas
$19.05M (5) scheduled
−$19.05M
77,998
$3.17M
+92.2%
Accogli Giuseppe
EVP, Chief Operating Officer
$13.14M (5) scheduled
−$13.14M
130,805
$5.31M
+63.5%
Martin Sean
SVP and General Counsel
$803.82K (1)
$6.93M (5) scheduled
−$6.13M
52,632
$2.14M
+4,225%
Franzi Cristiano
SVP, President, EMEA
$4.08M (2) scheduled
−$4.08M
102,145
$4.15M
+4,100%
Pleau Scott
SVP, Operations
$3.58M (3) scheduled
−$3.58M
20,076
$815.29K
−1.9%
GAVIN JAMES R III
Director
$3.42M (6) scheduled
−$3.42M
39,508
$1.60M
+23.7%
STORM KORNELIS J.
Director
$3.30M (3) scheduled
−$3.30M
22,512
$914.21K
+7.0%
Shapazian Carole J
Director
$3.09M (9) scheduled
−$3.09M
9,848
$399.93K
+6.7%
STROUCKEN ALBERT P L
Director
$2.15M (10) scheduled
−$2.15M
69,800
$2.83M
+28.4%
HELLMAN PETER S
Director
$1.99M (9) scheduled
−$1.99M
30,335
$1.23M
+34.5%
FORSYTH JOHN D
Director
$1.76M (13) scheduled
−$1.76M
27,029
$1.10M
−3.9%
STALLKAMP THOMAS T
Director
$1.73M (9) scheduled
−$1.73M
11,576
$470.10K
−5.7%
Frye Andrew
SVP, President, APAC
$1.57M (3)
−$1.57M
22,002
$893.50K
+3,269%
Kunzler Jacqueline
SVP, Chief Quality Officer
$725.04K (3)
−$725.04K
22,625
$918.80K
+264.2%
Stevens Brian
SVP, CAO & Controller
$213.76K (2)
−$213.76K
67,538
$2.74M
+2,988%
Chen Thomas F
Director
$142.01K (1) scheduled
−$142.01K
15,740
$639.20K
+865.6%
Hider Andrew P.
President and CEO
518,447
$21.05M
+17,971%
Grade Joel T.
EVP and CFO
271,674
$11.03M
+3,989%
ALMEIDA JOSE E
Chairman, CEO, President
243,589
$9.89M
SACCARO JAMES
EVP, Chief Financial Officer
177,899
$7.22M
+289.7%
Knight Heather
EVP, Chief Operating Officer
177,362
$7.20M
+340.7%
Rosenbloom David S.
EVP and General Counsel
138,216
$5.61M
+1,971%
Sonig Alok
EVP,Group President,Pharma
128,219
$5.21M
+472.8%
Rasul Reazur
EVP,Group Pres,Healthcare
125,557
$5.10M
+624.5%
Scharf David P.
CVP and General Counsel
109,789
$4.46M
+15.5%
Toth Christopher A.
EVP, Group Pres, Kidney Care
105,186
$4.27M
Soriano Maria Cecilia
Group Pres., ITT & Pharma.
75,045
$3.05M
+37.3%
Shafer David Brent
Director
72,804
$2.96M
+3,522%
Borzi James W
EVP,Chief Supply Chain Officer
71,948
$2.92M
+1,982%
Wallace Steven P.
President, Adv. Surgery
70,128
$2.85M
−0.2%
Zielinski Anita A
SVP, Interim CFO, CAO & Cntrlr
59,714
$2.42M
+25,528%
Vibert Paul
CVP, International
51,283
$2.08M
+10.6%
Wendell Amy McBride
Director
44,235
$1.80M
+687.1%
MORRISON PATRICIA
Director
42,386
$1.72M
+2,187%
Wilkes David S.
Director
37,076
$1.51M
+2,914%
Oesterle Stephen N.
Director
35,847
$1.46M
+1,481%
Schabacker Marcus
CVP, Chief Scientific Officer
35,602
$1.45M
+17.6%
SCHLICHTING NANCY M
Director
34,994
$1.42M
+3,396%
Flynn Steven
SVP, President, APAC
31,080
$1.26M
+157.9%
Ampofo William A. II
Director
30,375
$1.23M
+5,022%
Teaff James
President, CCS
30,370
$1.23M
−3.4%
Smith Cathy R
Director
30,345
$1.23M
+1,751%
Carlisle Cynthia
Executive Vice President, CHRO
29,677
$1.21M
Foster Julie
President, Front Line Care
29,164
$1.18M
−6.7%
Craig Jeffrey A
Director
23,662
$960.91K
+13,737%
RUSCKOWSKI STEPHEN H
Director
16,499
$670.02K
+5,138%
McDonnell Michael R.
Director
14,647
$594.81K
WILVER PETER M
Director
13,267
$538.77K
+4,983%
Karp Caroline
SVP, Controller
12,557
$509.94K
+9.3%
Mahoney Michael F
Director
9,692
$393.59K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Stevens Brian
28 Feb 2022
SVP, CAO and Controller
Sell
175
$86.07
$15.06K
Stevens Brian
28 Feb 2022
SVP, CAO and Controller
Sell
2,325
$85.46
$198.69K
Frye Andrew
12 Apr 2021
SVP, President, APAC
Sell
10,999
$84.79
$932.61K
Frye Andrew
3 Jun 2020
SVP, President, APAC
Sell
3,742
$91.00
$340.52K
Frye Andrew
14 Oct 2019
SVP, President, APAC
Sell
3,332
$88.00
$293.22K
Kunzler Jacqueline
5 Sep 2019
SVP, Chief Quality Officer
Sell
5,934
$88.12
$522.90K
Kunzler Jacqueline
19 Jun 2019
SVP, Chief Quality Officer
Sell
593
$80.46
$47.71K
Third Point LLC
16 May 2019
Director
Sell indirect
5,000,000
$76.37
$381.85M
STALLKAMP THOMAS T
1 May 2019
Director
Sell
1,000
$76.20
$76.20K
STALLKAMP THOMAS T
1 Apr 2019
Director
Sell
1,043
$82.07
$85.60K
STALLKAMP THOMAS T
1 Mar 2019
Director
Sell
1,000
$75.16
$75.16K
STALLKAMP THOMAS T
1 Feb 2019
Director
Sell
1,638
$73.75
$120.80K
STALLKAMP THOMAS T
18 Jan 2019
Director
Sell
3,187
$70.00
$223.09K
Third Point LLC
3 Dec 2018
Director
Sell indirect
8,000,000
$68.62
$548.96M
Third Point LLC
6 Nov 2017
Director
Sell indirect
5,000,000
$64.23
$321.15M
Third Point LLC
1 Jun 2017
Director
Sell indirect
5,000,000
$59.50
$297.50M
Shapazian Carole J
23 May 2017
Director
Sell
2,618
$57.92
$151.63K
Third Point LLC
28 Feb 2017
Director
Sell indirect
5,901,767
$50.35
$297.15M

What was left out

Form 4 filings counted 518
Amendments (4/A) skipped 1
Filings about a different issuer 1
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 84
Sales at will 18
Transactions with no price 0
Shares from compensation/vesting 6,194,593
Sales filed before the plan box existed 18
History held since 30 Aug 2016